By any standard, the pharmaceutical industry's history has been a successful one. In addition to its profits and shareholder dividends, it has been seen by investors as relatively low risk and, largely, counter-cyclical to stock market trends. However, that important contribution appears to be petering out, with significant global implications for employees, shareholders, governments and patients. This is not just caused by the economic crisis. Long before this, several distinct but related streams of evidence emerged that now point to the stalling of the pharmaceutical industry. The Future...

The Role of the Military in Protecting the World's Water Resources Proceedings is a workshop hosted and conducted by the Center for Strategic Leadership of the U.S. army war college and sponsored by the Principal Assistant Deputy Under Secretary of Defense on 3/5 November 1999.

Darwin s Medicine is the sequel to Brian D. Smith s influential and critically acclaimed Future of Pharma (Gower, 2011). Whereas the earlier book predicted the evolution of the pharmaceutical market and the business models of pharmaceutical companies, Darwin s Medicine goes much deeper into the drivers of industry change and how leading pharmaceutical and medical technology companies are adapting their strategies, structures and capabilities in practice.

Through the lens of evolutionary science, Professor Smith explores the speciation of new business...